News

Mukesh Jain, chairman of Jainsons, said: “This is a very innovative and exciting technological breakthrough for breast cancer detection. This can revolutionize the breast cancer industry and has

Cephalon, a biopharmaceutical company, has reported positive results from a Phase II clinical trial of Nuvigil tablets as adjunctive therapy for treating major depressive disorder in adults with

In this role, Dr Gardiner will be responsible for leading and coordinating investigator-initiated research projects, clinical publications and presentations and overall medical support for the clinical collaborators and

This X-Suit NIR stent will launch in Europe and parts of Asia on March 27, 2009 followed by the US on April 24, 2009. In Japan and other

Ovation has received $600 million of cash consideration at closing and will receive up to an additional $300 million based on certain regulatory milestones for Sabril (vigabatrin), a

Engle’s background also includes senior executive positions with Merck Generics Group, a division of Merck KGaA, and Allergan, Inc. “I’m very pleased that Mel has agreed to join

Canada-based ConjuChem Biotechnologies, which is engaged in the discovery of therapeutics with an initial focus on diabetes, has reported a net loss of $5.83m, or $0.02 per share,

Intravascular ultrasound technology enables physicians to see detailed images inside the heart and coronary arteries. The company said the iCross catheter would be available immediately in the US.

The lawsuits are based on abbreviated new drug applications (ANDA) filed by Teva and Mylan seeking permission to manufacture and market a generic version of Tarceva before the